v3.19.3
Condensed Consolidated Interim Statements of Operations and Comprehensive (Loss) - USD ($)
3 Months Ended 6 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Condensed Consolidated Interim Statements of Operations and Comprehensive (Loss)        
Sales $ 281,691 $ 547,085 $ 1,072,070 $ 1,048,418
Cost of Sales 83,207 384,073 419,292 637,236
Gross Margin 198,484 163,012 652,778 411,182
Operating expenses        
Sales and marketing 584,775 427,325 1,168,507 969,984
Research and development 886,060 679,049 1,702,583 1,355,792
General and administrative 1,199,938 931,477 2,041,631 1,910,956
Share-based compensation expense (Note 11) 638,219 439,328 925,976 1,034,740
Amortization (Note 4) 69,314 69,315 138,628 140,368
Depreciation (Note 7) 27,059 16,626 51,029 34,221
Total operating expenses 3,405,365 2,563,120 6,028,354 5,446,061
Other (income) expenses        
Accretion expense 0 1,970,167 0 2,104,418
Fair Value Adjustment 0 (382,010) 0 (337,923)
Gain/Loss on mark to market re-evaluation 0 0 0 (2,048,697)
Other expense 170,739 22,712 185,035 60,132
Foreign exchange 5,064 (27,872) (57,283) (69,006)
Total other expenses (income) 175,803 1,582,997 127,752 (291,076)
Net (loss) and comprehensive (loss) for the period $ (3,382,684) $ (3,983,105) $ (5,503,328) $ (4,743,803)
Loss per share - basic and diluted $ (0.87) $ (1.62) $ (1.42) $ (2.02)
Weighted average number of shares outstanding - basic and diluted 3,872,428 2,459,169 3,865,573 2,351,587

Source